SCHEMBL7317034

SCHEMBL7317034

FN1CCN(C(c2ccccc2)c2ccccc2)CC1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.67
CHRM2 P08172 2/20 0.67
ADRA2A P08913 2/20 0.67
CHRM1 P11229 2/20 0.67
DRD1 P21728 2/20 0.67
DRD3 P35462 2/20 0.67
SLC6A3 Q01959 2/20 0.67
KCNH2 Q12809 2/20 0.67
CYP2D6 P10635 2/20 0.67
CHRM4 P08173 1/20 0.67
CHRM5 P08912 1/20 0.67
ADORA3 P0DMS8 1/20 0.67
CHRM3 P20309 1/20 0.67
ADRA1D P25100 1/20 0.67
HTR2A P28223 1/20 0.67
HTR2C P28335 1/20 0.67
HRH1 P35367 1/20 0.67
HTR2B P41595 1/20 0.67
KMT2A Q03164 5/20 0.61
MEN1 O00255 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3919536 0.91 OPRM1 (0.78) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL8186671 0.91 OPRM1 (0.78) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL8175607 0.91 OPRM1 (0.78) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL7977689 0.91 OPRM1 (0.78) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL16448455 0.84 OPRM1 (0.70) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL8176312 0.82 OPRM1 (0.67) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL2054235 0.81 CYP2D6 (0.67) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL1502253 0.81 CYP2D6 (0.65) OPRM1CHRM2ADRA2ACHRM1DRD1
Cyclizine SCHEMBL4690 0.80 CYP2D6 (1.00) OPRM1CHRM2ADRA2ACHRM1DRD1
SCHEMBL467087 0.80 OPRM1 (0.64) OPRM1CHRM2ADRA2ACHRM1DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP claimed
WO-2012077133-A1 PROCESSES FOR PREPARATION OF MONTELUKAST SODIUM AND PURIFICATION OF DIOL INTERMEDIATE IND-SWIFT LABORATORIES LIMITED (IN) 2012-06-14 WO disclosed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
US-4663325-A 1-(2,3,4-tri-methoxybenzyl)-4[bis(4-fluorophenyl)methyl] piperazines are useful for treating cerebrovascular disease KANEBO LTD. (JP) 1987-05-05 US disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed
EP-0159566-A1 Novel piperazine derivatives, processes for production thereof, and pharmaceutical compositions comprising said compounds as active ingredient KANEBO, LTD. (JP) 1985-10-30 EP disclosed